CGT

830개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved830 programs
CGTLimited DatastaleThe Pregene (ShenZhen) Biotechn…Phase 1

CAR19 T cells carrying cytoplasmic activated PD-1 (CAR19 T cells carrying cytoplasmic activated PD-1)

Relapsed Non Hodgkin Lymphoma · PD-1

#PD-1#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleUniversity College, LondonPhase 1

CAR19 T-Cells (CAR19 T-Cells)

Diffuse Large B-Cell Lymphoma · Diffuse Large B-Cell Lymphoma

#DiffuseLargeB-CellLymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleHebei Taihe Chunyu Biotechnolog…Phase 1

CAR19-BCMA dual-target CAR-T (CAR19-BCMA dual-target CAR-T)

Multiple Myeloma · BCMA

#BCMA#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleAffiliated Hospital to Academy …Phase 1

CAR19BCMA-T cells (CAR19BCMA-T cells)

Relapsed or Refractory Plasma Cell Neoplasms; Lymphomas/Leukemias With Plasmacytic Differentiation · BCMA

#BCMA#CGT#Phase1#cell-gene-therapy#CAR-T+5
Trials 1Status Recruiting
CGTLimited DatastaleChinese PLA General HospitalPhase 2

CAR19TIF cells (CAR19TIF cells)

B Cell Lymphoma · B Cell Lymphoma

#BCellLymphoma#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleElicera TherapeuticsPhase 2

CAR20 (NAP, CAR20, CAR20(NAP)-T)

B-cell Lymphoma · B-cell Lymphoma

#B-cellLymphoma#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleAffiliated Hospital to Academy …Phase 2

CAR2219-T cells (CAR2219-T cells)

Relapsed or Refractory B Cell Leukemia and Lymphoma · FRα

#FR#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleUniversity College, LondonPhase 1

CARCCR9 T cells (CARCCR9 T cells)

T Cell Acute Lymphoblastic Leukemia; T Cell Lymphoblastic Lymphoma · T Cell Acute Lymphoblastic Leukemia

#TCellAcuteLymphoblasticLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleBaylor College of MedicinePhase 1

CARE T cells (CARE T cells)

Liver Cancer; Rhabdomyosarcoma · Liver Cancer

#LiverCancer#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleUnion Hospital, Tongji Medical …Phase 1

CART Infusion (CART Infusion)

Autoimmune Hemolytic Anemia; Primary Immune Thrombocytopenic Purpura · Autoimmune Hemolytic Anemia

#AutoimmuneHemolyticAnemia#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleYake Biotechnology Ltd.Phase 2

CART therapy (CART therapy)

Neuroblastoma (NB); Desmoplastic Small Round Cell Tumor (DSRCT) · Neuroblastoma (NB)

#NeuroblastomaNB#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleShanghai Unicar-Therapy Bio-med…Phase 2

CART-19/22 (CART-19/22)

Leukemia, B-cell · Leukemia, B-cell

#LeukemiaB-cell#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleShanghai Simnova Biotechnology …Phase 1

CART-BCMA (CART-BCMA)

Multiple Myeloma · BCMA

#BCMA#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleUniversity of PennsylvaniaPhase 1

CART-EGFR-IL13Ra2 T cells (CART-EGFR-IL13Ra2 T cells)

Recurrent Glioblastoma · EGFR

#EGFR#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleShenzhen BinDeBio Ltd.Preclinical

CART-meso cells (CART-meso cells)

Pancreatic Cancer · Pancreatic Cancer

#PancreaticCancer#CGT#Preclinical#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleGyala TherapeuticsPhase 2

CART84 (CART84)

Acute Myeloblastic Leukaemia; Leukemia, T-Cell · Acute Myeloblastic Leukaemia

#AcuteMyeloblasticLeukaemia#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleFundación Pública Andaluza para…Phase 2

CARTemis-1 (CARTemis-1)

Multiple Myeloma; Allogeneic Stem Cell Transplantation · Multiple Myeloma

#MultipleMyeloma#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleMarcela V. Maus, M.D.,Ph.D.Phase 1

CARv3-TEAM-E T cells (CARv3-TEAM-E T cells)

Glioblastoma; Malignant Glioma · Glioblastoma

#Glioblastoma#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleZhejiang Provincial People's Ho…Phase 1

CB CAR-NK18.2 (CB CAR-NK18.2)

Gastric Cancer; Pancreas Adenocarcinoma · Gastric Cancer

#GastricCancer#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleSecond Affiliated Hospital, Sch…Phase 1

CB dualCAR-NK19/70 (CB dualCAR-NK19/70)

B-cell Non Hodgkin Lymphoma · B-cell Non Hodgkin Lymphoma

#B-cellNonHodgkinLymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active

23 / 42 pages

← PreviousNext →